Study of Ventilator Associated Event During Intensive Care After Resuscitated Cardiac Arrest.
VAE-ACR
1 other identifier
observational
150
1 country
1
Brief Summary
The aim is to describe the incidence, characteristics, risk factors and outcome of complications acquired under mechanical ventilation (called ventilator-associated events) according to the new CDC criteria, in a population of patients admitted in intensive care unit after cardiac arrest.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 14, 2024
CompletedFirst Posted
Study publicly available on registry
June 20, 2024
CompletedStudy Start
First participant enrolled
June 27, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedMarch 14, 2025
March 1, 2025
1.5 years
June 14, 2024
March 12, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
number
Incidence of ventilator associated event
at day 28
Secondary Outcomes (4)
Associated factors
at day 28
number of pneumonias
at day 28
time
at day 28
number of deaths
at day 28
Interventions
Measure of incidence of Ventilator associated event
Eligibility Criteria
Patient admitted to intensive care unit after cardiac arrest at the South Francilien Hospital Center from January 2019 to December 2023
You may qualify if:
- Adult male or female
- Non-pregnant female
- Successfully resuscitated from cardiac arrest during primary care
- Invasive mechanical ventilation initiated during resuscitation and continued for at least 4 days
- No decision to limit life-sustaining therapies within 24 hours following admission to intensive care
- No requirement of arteriovenous circulatory support during intensive care management
You may not qualify if:
- \- patients who opposed to the use of their data
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre Hospitalier Sud Francilien
Corbeil-Essonnes, 91106, France
Related Publications (2)
American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005 Feb 15;171(4):388-416. doi: 10.1164/rccm.200405-644ST. No abstract available.
PMID: 15699079BACKGROUNDPerbet S, Mongardon N, Dumas F, Bruel C, Lemiale V, Mourvillier B, Carli P, Varenne O, Mira JP, Wolff M, Cariou A. Early-onset pneumonia after cardiac arrest: characteristics, risk factors and influence on prognosis. Am J Respir Crit Care Med. 2011 Nov 1;184(9):1048-54. doi: 10.1164/rccm.201102-0331OC.
PMID: 21816940BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 14, 2024
First Posted
June 20, 2024
Study Start
June 27, 2024
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
March 14, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share